SCHEMBL18668012

SCHEMBL18668012

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-n4c5cc6ccccc6cc5c5c6ccccc6c6ccccc6c54)cc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.35
MEN1 O00255 6/20 0.35
ALDH1A1 P00352 4/20 0.35
MAPT P10636 3/20 0.35
HPGD P15428 2/20 0.35
RXRA P19793 1/20 0.34
ATM Q13315 1/20 0.34
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
LMNA P02545 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SIRT1 Q96EB6 1/20 0.32
ABCG2 Q9UNQ0 2/20 0.32
KDM4E B2RXH2 2/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18668008 0.99 MEN1 (0.34) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL18668013 0.95 MEN1 (0.37) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL18667507 0.94 KMT2A (0.41) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL18667907 0.94 KMT2A (0.41) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL18667512 0.93 KMT2A (0.40) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL18667701 0.92 HTR6 (0.35) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL18667588 0.90 MEN1 (0.36) KMT2AMEN1MAPTESR1ESR2
SCHEMBL18667908 0.90 CYP1A1 (0.44) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL19844123 0.90 MEN1 (0.35) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL19844118 0.89 ESR1 (0.35) KMT2AMEN1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2019-09-24 US disclosed
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-08 US disclosed
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-08 US disclosed
WO-2017047992-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2017-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, CRY2, PER2 KMT2A 828/4885MEN1 838/4885ALDH1A1 486/4885
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, PER2 KMT2A 828/4885MEN1 838/4885ALDH1A1 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.